TipRanks
Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD)
NASDAQ:HKPD
US Market
HKPD
Hong Kong Pharma Digital Technology Holdings Ltd.
RESEARCH TOOLSreports

Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD) Ratios

22 Followers

Hong Kong Pharma Digital Technology Holdings Ltd. Ratios

HKPD's free cash flow for Q4 2026 was $0.07. For the 2026 fiscal year, HKPD's free cash flow was decreased by $ and operating cash flow was $-0.19. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 3.86 3.86 2.99 2.46
Quick Ratio
 3.75 3.75 2.80 2.16
Cash Ratio
 0.07 0.07 0.26 0.20
Solvency Ratio
 -0.32 -0.32 0.24 0.51
Operating Cash Flow Ratio
 -0.24 -0.24 0.20 -0.12
Short-Term Operating Cash Flow Coverage
 -0.86 -0.86 1.53 -1.83
Net Current Asset Value
$ 9.07M$ 9.07M$ 4.30M$ 3.39M
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.10 0.25 0.24
Debt-to-Equity Ratio
 0.13 0.13 0.48 0.49
Debt-to-Capital Ratio
 0.12 0.12 0.32 0.33
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.23 0.21
Financial Leverage Ratio
 1.34 1.34 1.89 2.04
Debt Service Coverage Ratio
 -0.92 -0.92 2.44 7.85
Interest Coverage Ratio
 -7.46 -7.46 1.35 19.43
Debt to Market Cap
 0.69 0.07 0.19 0.06
Interest Debt Per Share
 0.04 0.06 0.27 0.29
Net Debt to EBITDA
 -1.13 -1.13 1.35 0.58
Profitability Margins
Gross Profit Margin
10.32%10.32%11.89%21.32%
EBIT Margin
-7.48%-7.48%0.66%9.64%
EBITDA Margin
-6.84%-6.84%5.94%15.19%
Operating Profit Margin
-7.41%-7.41%0.65%9.64%
Pretax Profit Margin
-8.40%-8.40%0.18%9.14%
Net Profit Margin
-8.46%-8.46%-0.13%7.97%
Continuous Operations Profit Margin
-8.46%-8.46%-0.13%7.97%
Net Income Per EBT
100.68%100.68%-74.92%87.14%
EBT Per EBIT
113.41%113.41%27.35%94.88%
Return on Assets (ROA)
-8.84%-8.84%-0.29%15.34%
Return on Equity (ROE)
-15.43%-11.85%-0.54%31.26%
Return on Capital Employed (ROCE)
-10.31%-10.31%2.03%29.29%
Return on Invested Capital (ROIC)
-9.18%-9.18%-1.34%22.10%
Return on Tangible Assets
-8.90%-8.90%-0.29%15.40%
Earnings Yield
-27.21%-8.50%-0.28%6.40%
Efficiency Ratios
Receivables Turnover
 3.54 3.54 4.31 4.49
Payables Turnover
 7.83 7.83 10.36 9.92
Inventory Turnover
 33.45 33.45 31.96 14.07
Fixed Asset Turnover
 30.94 30.94 34.21 20.02
Asset Turnover
 1.05 1.05 2.16 1.93
Working Capital Turnover Ratio
 1.79 1.80 3.89 6.92
Cash Conversion Cycle
 67.42 67.42 60.87 70.50
Days of Sales Outstanding
 103.15 103.15 84.69 81.33
Days of Inventory Outstanding
 10.91 10.91 11.42 25.95
Days of Payables Outstanding
 46.64 46.64 35.23 36.78
Operating Cycle
 114.06 114.06 96.11 107.28
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.03 0.06 -0.05
Free Cash Flow Per Share
 -0.02 -0.03 0.05 -0.07
CapEx Per Share
 <0.01 <0.01 0.02 0.01
Free Cash Flow to Operating Cash Flow
 1.05 1.05 0.73 1.22
Dividend Paid and CapEx Coverage Ratio
 -21.19 -21.19 3.67 -4.48
Capital Expenditure Coverage Ratio
 -21.19 -21.19 3.67 -4.48
Operating Cash Flow Coverage Ratio
 -0.60 -0.60 0.24 -0.19
Operating Cash Flow to Sales Ratio
 -0.06 -0.06 0.03 -0.02
Free Cash Flow Yield
-61.80%-5.89%4.25%-2.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.32 -11.77 -400.00 15.62
Price-to-Sales (P/S) Ratio
 0.09 0.99 0.48 1.24
Price-to-Book (P/B) Ratio
 0.44 1.39 1.95 4.88
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.62 -16.97 23.52 -43.06
Price-to-Operating Cash Flow Ratio
 -5.56 -17.78 17.12 -52.67
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 3.94 0.16
Price-to-Fair Value
 0.44 1.39 1.95 4.88
Enterprise Value Multiple
 -2.52 -15.68 9.42 8.77
Enterprise Value
 2.31M 14.40M 11.37M 22.24M
EV to EBITDA
 -2.52 -15.68 9.42 8.77
EV to Sales
 0.17 1.07 0.56 1.33
EV to Free Cash Flow
 -2.93 -18.29 27.45 -46.10
EV to Operating Cash Flow
 -3.07 -19.15 19.97 -56.39
Tangible Book Value Per Share
 0.26 0.40 0.54 0.57
Shareholders’ Equity Per Share
 0.27 0.41 0.55 0.58
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 1.75 0.13
Revenue Per Share
 0.37 0.57 2.25 2.27
Net Income Per Share
 -0.03 -0.05 >-0.01 0.18
Tax Burden
 1.01 1.01 -0.75 0.87
Interest Burden
 1.12 1.12 0.27 0.95
Research & Development to Revenue
 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.18 0.18 0.11 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00
Income Quality
 0.66 0.66 -21.04 -0.30
Currency in USD